Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer by Clarissa Lam, Debra Sarasohn, Britta Weigelt, Dmitriy Zamarin

Subjects: Get full text

Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy by Burgio V, Iavarone M, Di Costanzo GG, Marra F, Lonardi S, Tamburini E, Piscaglia F, Masi G, Celsa C, Foschi FG, Silletta M, Amoruso DC, Rimini M, Bruccoleri M, Tortora R, Campani C, Soldà C, Viola MG, Forgione A, Conti F, Salani F, Catanese S, Giacchetto CM, Fulgenzi C, Coppola C, Lampertico P, Pellino A, Rancatore G, Cabibbo G, Ratti F, Pedica F, Della Corte A, Colombo M, De Cobelli F, Aldrighetti L, Cascinu S, Casadei-Gardini A

Subjects: Get full text

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma by Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, Takeshi Mitsuhashi, Akihiro Hirao, Takahiro Tanaka, Tatsuya Taniguchi, Koichi Okamoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Tetsuji Takayama

Subjects: Get full text

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma by Keisuke Koroki, Naoya Kanogawa, Susumu Maruta, Sadahisa Ogasawara, Yotaro Iino, Masamichi Obu, Tomomi Okubo, Norio Itokawa, Takahiro Maeda, Masanori Inoue, Yuki Haga, Atsuyoshi Seki, Shinichiro Okabe, Yoshihiro Koma, Ryosaku Azemoto, Masanori Atsukawa, Ei Itobayashi, Kenji Ito, Nobuyuki Sugiura, Hideaki Mizumoto, Hidemi Unozawa, Terunao Iwanaga, Takafumi Sakuma, Naoto Fujita, Hiroaki Kanzaki, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Jun Kato, Naoya Kato

Subjects: Get full text

Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroi... by Giovanna Revilla, Nuseibah Al Qtaish, Pablo Caruana, Myriam Sainz-Ramos, Tania Lopez-Mendez, Francisco Rodriguez, Verónica Paez-Espinosa, Changda Li, Núria Fucui Vallverdú, Maria Edwards, Antonio Moral, José Ignacio Pérez, Juan Carlos Escolà-Gil, José Luis Pedraz, Idoia Gallego, Rosa Corcoy, María Virtudes Céspedes, Gustavo Puras, Eugènia Mato

Subjects: Get full text

Use of multikinase inhibitors/lenvatinib concomitant with locoregional therapies for the treatment of radioiodine‐refractory differentiated thyroid cancer by Miguel‐Ángel Berciano‐Guerrero

Subjects: Get full text

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma by Jonathan T. Hunt, Laura M. Chambers, Meng Yao, Amy Joehlin-Price, Robert Debernardo, Peter G. Rose

Subjects: Get full text

A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician’s Choice in a New Ther... by Dipasquale A, Marinello A, Santoro A

Subjects: Get full text

Lenvatinib‐associated hemoperitoneum in a patient with primary angiosarcoma of the breast by Ijeoma Orabueze, Inemesit Akpan, Ryan Denley

Subjects: Get full text

Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia by Ai Kuwahara, Ryu Sasaki, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Kazuhiko Nakao

Subjects: Get full text

Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma by Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, Licht Tominaga, Akira Kajiwara, Kayoko Kasuya, Soichi Iritani, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Tokuyo Kozuka, Hiromitsu Kumada

Subjects: Get full text

Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib by Yen-Yang Chen, Chih-Chi Wang, Yueh-Wei Liu, Wei-Feng Li, Yen-Hao Chen

Subjects: “…Lenvatinib…”
Get full text

Thrombotic microangiopathy associated with lenvatinib therapy by Macarena Contreras Angulo, Belén García Izquierdo, Laura Armengod Grao, Nuria Palacios García

Subjects: “…lenvatinib…”
Get full text

Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report by Zhaonan Liu, Xingjie Li, Xuequn He, Yingchun Xu, Xi Wang

Subjects: Get full text

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis by Katsuya Toshida, Shinji Itoh, Norifumi Iseda, Shugo Tanaka, Kensuke Nakazono, Takahiro Tomiyama, Shohei Yoshiya, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Koji Taniguchi, Yoshinao Oda, Tomoharu Yoshizumi

Subjects: Get full text

Novel insights into post-marketing adverse events associated with lenvatinib: A comprehensive analysis utilizing the FAERS database by Zhe Yu, Jing Luo, Hongshan Wei

Subjects: “…lenvatinib…”
Get full text

Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma by Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka, Masamichi Obu, Masanori Inoue, Norio Itokawa, Yuki Haga, Atsuyoshi Seki, Shinichiro Okabe, Ryosaku Azemoto, Ei Itobayashi, Masanori Atsukawa, Nobuyuki Sugiura, Hideaki Mizumoto, Keisuke Koroki, Kengo Kanayama, Hiroaki Kanzaki, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Naoya Kato

Subjects: Get full text

Lenvatinib targets STAT-1 to enhance the M1 polarization of TAMs during hepatocellular carcinoma progression by Peng Sun, Zhenfeng Li, Zaojun Yan, Zhaofeng Wang, Peng Zheng, Mingliang Wang, Xu Chang, Zihao Liu, Jianxin Zhang, Huiyong Wu, Wenbo Shao, Dewen Xue, Jinming Yu

Subjects: “…Lenvatinib…”
Get full text

Safety and efficacy of radiotherapy combined with lenvatinib plus PD-1 inhibitors as neo-adjuvant therapy in hepatocellular carcinoma with portal vein thrombus: protocol of an open... by Guangxin Li, Bin Shu, Zhuozhao Zheng, Hongfang Yin, Chen Zhang, Ying Xiao, Yanmei Yang, Zhe Yan, Xiaofei Zhang, Shizhong Yang, Gong Li, Jiahong Dong, Jiahong Dong

Subjects: Get full text

Efficacy of lenvatinib versus sorafenib in the primary treatment of advanced hepatocellular carcinoma: A meta‐analysis by Vikash Jaiswal, Maha Hameed, Sidra Naz, Poulami Roy, Novonil Deb, Janta Ukrani, Gautham Varun Krishna Mohan, Amira M Taha, Helen Huang, Vikash Kumar, Bhavyakumar Vachhani, Abdelrahman M Attia, Supti D Nath, Mostafa A Solimn, Dattatreya Mukherjee

Subjects: Get full text